pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Rare Disease · news · pharmadog
← back to Rare Disease
News · Rare Disease
846
stories
Aug 28, 26
STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
stat
Aug 28, 26
Vaccines take center stage at federal autism advisory committee
stat
Aug 27, 26
Roivant's dermatomyositis drug Lisraya snags FDA approval
endpoints
Aug 27, 26
STAT+: FDA approves Roivant therapy for rare autoimmune disease
stat
Aug 27, 26
FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
fda press
Aug 27, 26
Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
fiercebiotech
Aug 27, 26
Opinion: I studied Reddit forums on menopause — and found what doctors are missing
stat
Aug 27, 26
STAT+: The mystery of Moderna’s magic algorithm
stat
Aug 27, 26
Fragile X at a turning point: Breaking through the clinical bottleneck
biospace
Aug 27, 26
CAR Ts will only treat autoimmune diseases if we can scale delivery
biospace
Aug 26, 26
Biohaven trades cash for ‘upside’ with $795M epilepsy drug deal
biopharma dive
Aug 26, 26
FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
fda press
Aug 26, 26
Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial
biopharma dive
Aug 26, 26
Biohaven could get up to $795M in epilepsy alliance with SK Bio
biospace
Aug 25, 26
After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platform
fiercebiotech
Aug 25, 26
J&J’s Imaavy wins label expansion; Two approvals in Japan
endpoints
Aug 25, 26
STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs
stat
Aug 25, 26
STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
stat
Aug 24, 26
Safety concerns spur FDA to again halt testing of Regenxbio gene therapy
biopharma dive
Aug 24, 26
FDA extends review of Capricor cell therapy; Pain drug startup to go public
biopharma dive
Aug 24, 26
STAT+: Lady Gaga and her fiancé launch a biotech startup
stat
Aug 24, 26
REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans
biospace
Aug 24, 26
STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
stat
Aug 24, 26
STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
stat
Aug 24, 26
Option-to-acquire deals remain rare in biotech's buzzy M&A season
endpoints
Aug 24, 26
Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug
fiercebiotech
Aug 24, 26
STAT+: Inside Moderna and Merck’s cancer vaccine triumph
stat
Aug 24, 26
Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings
fiercebiotech
Aug 24, 26
Capricor, Replimune reviews signal FDA’s return to reliability but every application will stand alone
biospace
Aug 23, 26
Why a Texas congressman believes Chinese biotechs are 'beating us on our ground game'
fiercebiotech
← prev
page 10 of 29
next →
